Armbruster Appointed to ACC/AHA Joint Committee on Clinical Practice Guidelines
Published on 02 June 2020
Anastasia Armbruster, Pharm.D. ’09, AACC, BCPS, BCCP, associate professor of pharmacy practice, was appointed to the American College of Cardiology (ACC)/American Heart Association (AHA) Joint Committee on Clinical Practice Guidelines, which works to update best practice guidelines that support health care providers as they make decisions on patient care.
Armbruster, who was selected by the ACC, will be one of three pharmacy representatives on the committee, which is comprised of 16 individuals from various health care professions.
“Practitioners depend on these guidelines to help them make decisions when treating patients,” Armbruster stated. “This committee guides the focus and topics of guidelines that ultimately provide best practice recommendations spanning all areas in cardiology.”
“New information in cardiology is coming out constantly, and having the different perspectives of numerous health care professions on the joint committee will allow us to deliver guidelines to practitioners with a consensus on the best way to treat their patients,” Armbruster continued.
Over the last few years, the ACC has worked to ensure that experts in a wide range of professions who comprise the cardiovascular treatment team, like physicians, pharmacists, nurses and others, are represented throughout the organization. The ACC also hopes to streamline and modernize their ability to deliver updated information accurately and efficiently to providers.
“It is an exciting time to be on the committee because I think things will look different in the next few years,” Armbruster stated. “This committee guides the review and delivery process, so we are looking for ways to innovate in order to ensure that the guidelines are not only up-to-date but also more user-friendly and easily accessible to clinicians. I am interested to see how we can improve on processes and contribute in the most effective way possible.”
During her two-year term, which began in April, Armbruster will convene with other committee members from across the country to discuss guideline updates, process improvements and innovations for final product accessibility. She is looking forward to the opportunity to make an impact and share her perspective from a pharmacist’s point of view.
“With a pharmacy background focused in cardiology, I do feel like I have input to give,” Armbruster said. “I’m excited to have the opportunity to work behind the scenes and represent my profession. There are only 16 people on the committee, so being one of a few pharmacists at the table is a big responsibility.”
As a faculty member and student mentor, Armbruster also recognizes the potential impact that her new appointment may have on future pharmacists by opening their eyes to the different ways that pharmacists can make a difference.“It’s important for pharmacy students to see their professors in roles like this because it helps them understand the wider impact of our profession,” Armbruster explained. “I think being able to talk to students about these opportunities and bringing our expertise and knowledge to them is extremely valuable.”